Evommune (EVMN) Amortizatization of Intangibles (2024 - 2026)
Evommune (EVMN) reported Amortizatization of Intangibles of $792000.0 for Q1 2026, up 86.35% year-over-year from $425000.0 in Q1 2025, and up 35.38% quarter-over-quarter from $585000.0 in Q4 2025.
Evommune (EVMN) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Amortizatization of Intangibles data on file, last reported at $792000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $792000.0, up 86.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (changed N/A YoY), and the FY2025 annual result was $1.8 million, down 2.8% from the prior year.
- Amortizatization of Intangibles rose to $792000.0 in Q1 2026 per EVMN's latest filing, from $585000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $792000.0 in Q1 2026 and troughed at $425000.0 in Q1 2025.
- A 3-year average of $562000.0 and a median of $515500.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 31.17% in 2025, then soared 86.35% in 2026.
- A 3-year view of Amortizatization of Intangibles shows it stood at $446000.0 in 2024, then jumped by 31.17% to $585000.0 in 2025, then jumped by 35.38% to $792000.0 in 2026.
- Business Quant data shows EVMN's Amortizatization of Intangibles at $792000.0 in Q1 2026, $585000.0 in Q4 2025, and $425000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - | 792,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 792,000.00 |
| Mar 31, 2026 | 792,000.00 |
| Dec 31, 2025 | 585,000.00 |
| Dec 31, 2025 | 585,000.00 |
| Mar 31, 2025 | 425,000.00 |
| Mar 31, 2025 | 425,000.00 |
| Dec 31, 2024 | 446,000.00 |
| Dec 31, 2024 | 446,000.00 |